122 related articles for article (PubMed ID: 8408733)
21. The effect of ciprofloxacin on the pharmacokinetic and ECG parameters of quinidine.
Bleske BE; Carver PL; Annesley TM; Bleske JR; Morady F
J Clin Pharmacol; 1990 Oct; 30(10):911-5. PubMed ID: 2229451
[TBL] [Abstract][Full Text] [Related]
22. Investigation of bioequivalence of a new fixed-dose combination of nifedipine and candesartan with the corresponding loose combination as well as the drug-drug interaction potential between both drugs under fasting conditions.
Brendel E; Weimann B; Dietrich H; Froede C; Thomas D
Int J Clin Pharmacol Ther; 2013 Sep; 51(9):753-62. PubMed ID: 23849325
[TBL] [Abstract][Full Text] [Related]
23. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
[TBL] [Abstract][Full Text] [Related]
24. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine].
Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M
Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425
[TBL] [Abstract][Full Text] [Related]
25. The pharmacokinetics and pharmacodynamics of nifedipine at steady state during concomitant administration of cimetidine or high dose ranitidine.
Khan A; Langley SJ; Mullins FG; Dixon JS; Toon S
Br J Clin Pharmacol; 1991 Oct; 32(4):519-22. PubMed ID: 1958451
[TBL] [Abstract][Full Text] [Related]
26. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S81-5. PubMed ID: 8793608
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes.
Choi YH; Lee MG
Xenobiotica; 2012 May; 42(5):483-95. PubMed ID: 22416982
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and pharmacodynamics of single oral doses of ibopamine, quinidine and their combination in normal man.
de Mey C; Enterling D; Brendel E; Wesche H
Eur J Clin Pharmacol; 1988; 34(4):415-8. PubMed ID: 3402527
[TBL] [Abstract][Full Text] [Related]
29. Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects.
Soons PA; van den Berg G; Danhof M; van Brummelen P; Jansen JB; Lamers CB; Breimer DD
Eur J Clin Pharmacol; 1992; 42(3):319-24. PubMed ID: 1577051
[TBL] [Abstract][Full Text] [Related]
30. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
[TBL] [Abstract][Full Text] [Related]
31. Effect of the combination of alinidine and other anti-anginal drugs on heart rate and blood pressure in healthy volunteers.
Harron DW; Deering AH; Scott M; McMahon M; Shanks RG
Br J Clin Pharmacol; 1989 Jan; 27(1):23-9. PubMed ID: 2495813
[TBL] [Abstract][Full Text] [Related]
32. A study of potential pharmacokinetic and pharmacodynamic interactions between dextromethorphan/quinidine and memantine in healthy volunteers.
Pope LE; Schoedel KA; Bartlett C; Sellers EM
Clin Drug Investig; 2012 Aug; 32(8):e1-15. PubMed ID: 22712629
[TBL] [Abstract][Full Text] [Related]
33. Quinidine-nifedipine interaction.
Van Lith RM; Appleby DH
Drug Intell Clin Pharm; 1985 Nov; 19(11):829-31. PubMed ID: 4064916
[TBL] [Abstract][Full Text] [Related]
34. Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine.
El-Eraky H; Thomas SH
Br J Clin Pharmacol; 2003 Aug; 56(2):198-204. PubMed ID: 12895193
[TBL] [Abstract][Full Text] [Related]
35. Drug-drug interactions: effect of quinidine on nifedipine binding to human cytochrome P450 3A4.
Koley AP; Robinson RC; Markowitz A; Friedman FK
Biochem Pharmacol; 1997 Feb; 53(4):455-60. PubMed ID: 9105395
[TBL] [Abstract][Full Text] [Related]
36. Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers.
Vianna-Jorge R; Sudo RT; Melo PA; Suarez-Kurtz G
Braz J Med Biol Res; 1992; 25(4):385-91. PubMed ID: 1342215
[TBL] [Abstract][Full Text] [Related]
37. Effect of an acute dose of alcohol on the pharmacokinetics of oral nifedipine in humans.
Qureshi S; Laganière S; Caillé G; Gossard D; Lacasse Y; McGilveray I
Pharm Res; 1992 May; 9(5):683-6. PubMed ID: 1608903
[TBL] [Abstract][Full Text] [Related]
38. Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.
Bauer LA; Murray K; Horn JR; Opheim K; Olsen J
Eur J Clin Pharmacol; 1989; 37(3):257-60. PubMed ID: 2612540
[TBL] [Abstract][Full Text] [Related]
39. Alteration of digoxin pharmacokinetics by a single dose of quinidine.
Chen TS; Friedman HS
JAMA; 1980 Aug; 244(7):669-72. PubMed ID: 6156244
[TBL] [Abstract][Full Text] [Related]
40. Heart rate variability in time and frequency domains: effects of gallopamil, nifedipine, and metoprolol compared with placebo.
Schweizer MW; Brachmann J; Kirchner U; Walter-Sack I; Dickhaus H; Metze C; Kübler W
Br Heart J; 1993 Sep; 70(3):252-8. PubMed ID: 8398496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
